Gynecology questions

A 30-year-old G1P1 woman presents to her primary care provider's office two weeks postpartum, actively breastfeeding her infant. She reports noticing a new, palpable lump in her right breast during her morning shower. She states the lump is not painful and denies any associated skin changes, nipple discharge, or systemic symptoms such as fever or chills. Her medical history is otherwise unremarkable, and she takes no regular medications. On physical examination, her vital signs are as follows: temperature 36.8 C, blood pressure 118/76 mmHg, pulse 72/min, and respirations 16/min. Palpation of the right breast reveals a single, periareolar, firm but mobile, well-circumscribed, and nontender mass, approximately 2 cm in diameter. There are no signs of inflammation or skin dimpling. An ultrasound examination of the breast is performed, revealing a well-defined, anechoic cystic lesion with posterior acoustic enhancement. Given these findings, what is the most likely diagnosis and the appropriate initial management strategy?

A 42-year-old G3P3003 woman presents to her primary care provider for follow-up after an abnormal screening mammogram. She reports regular menstrual cycles every 29 days and has a history of well-controlled essential hypertension. Her prior pregnancies were all uncomplicated vaginal deliveries. For contraception, she has been using condoms inconsistently. Her mother was diagnosed with breast cancer at age 65. On physical examination, her temperature is 36.80C, pulse is 76/min, blood pressure is 128/82 mmHg, and respirations are 14/min. Cardiopulmonary and abdominal exams are unremarkable. Pelvic examination reveals no abnormalities. A focused breast exam confirms a 2.5 cm firm, irregular, non-tender mass in the upper outer quadrant of her left breast, with no associated skin changes, nipple discharge, or axillary lymphadenopathy. She states she felt the lump herself about two months ago. Imaging from the screening mammogram indicated a highly suspicious lesion (BI-RADS 5), prompting further evaluation. Considering her clinical presentation and recent imaging findings, what is the most appropriate next diagnostic step and subsequent contraceptive recommendation for this patient?

A 16-year-old phenotypic female presents to a specialized reproductive endocrinology clinic for evaluation of primary amenorrhea. She is concerned that she has not yet undergone menarche, unlike her peers. She is an avid runner and has always been very lean. She denies cyclical abdominal pain, significant weight loss, or a calorie-restrictive diet. Her past medical history is unremarkable, and she takes no regular medications. Her vital signs are stable: temperature 37.10C, blood pressure 112/68 mmHg, pulse 71/min, and respirations 15/min. Physical examination reveals a well-nourished individual with Tanner stage IV breast development but a notable absence of pubic or axillary hair. Abdominal examination is non-tender and non-distended. A pelvic examination reveals a short, blind-ending vaginal canal with the absence of a cervix. A karyotype analysis performed reveals 46,XY chromosomes. Given these comprehensive findings, what is the most probable underlying diagnosis and the most critical initial management step?

A 30-year-old primigravida at 16 weeks gestation presents to an outpatient clinic complaining of persistent, severe vulvar itching and increased vaginal discharge for the past week. She describes the discharge as "white, thick, and cottage cheese-like." She also reports a recent history of antibiotic use for a urinary tract infection. Aside from the localized discomfort, she denies any other systemic symptoms like fever, dysuria, or abdominal pain. Her last obstetric visit was unremarkable. On physical examination, her vital signs are stable: temperature 36.8 0C, blood pressure 115/70 mmHg, pulse 78/min, and respirations 16/min. Inspection of the perineum reveals significant erythema and several superficial excoriations due to scratching. A speculum examination confirms the presence of copious, adherent, thick white discharge on the vaginal walls, with no evidence of cervical inflammation or friability. Microscopic examination of a vaginal wet mount shows abundant pseudohyphae and budding yeast forms. Given these clinical and laboratory findings, what is the most likely diagnosis and the most appropriate initial management strategy for this patient?

A 68-year-old female presents to an outpatient clinic with a chief complaint of intermittent vaginal spotting and light bleeding over the past two weeks. She reports using panty liners for management, but notes occasional soaking through a light pad. She achieved menopause 10 years prior. Her medical history includes well-controlled type 2 diabetes mellitus and essential hypertension. Her recent general check-up six months ago was unremarkable. On physical examination, her vital signs are: temperature 37.1 C, blood pressure 155/95 mmHg, pulse 68/min, respirations 14/min. Her body mass index is calculated at 30 kg/m2. Abdominal examination is soft, non-tender, with no palpable masses. Pelvic examination reveals a somewhat atrophic vaginal mucosa with a small amount of dark red blood emanating from the cervical os. The cervix appears unremarkable. Bimanual examination reveals an enlarged, boggy, and slightly irregular uterus, estimated to be consistent with a 12-week gestational size, without significant tenderness. No adnexal masses are appreciated. Rectovaginal examination is negative for masses or tenderness, and fecal occult blood test is negative. What are the most appropriate initial diagnostic and management steps for this patient?

A 28-year-old woman presents to a primary care clinic with concerns about difficulty conceiving for the past 18 months. She reports a long-standing history of irregular menstrual cycles, occurring every 35-60 days, since menarche at age 13. She has also noted progressive facial and body hair growth requiring frequent removal, and occasional acne breakouts. Her medical history is otherwise unremarkable, and she is not on any medications. On physical examination, her blood pressure is 138/88 mmHg. She has central adiposity with a body mass index (BMI) of 32 kg/m². Acanthosis nigricans is observed in her neck folds and axillae. Pelvic examination reveals no discrete adnexal masses, but bimanual palpation suggests bilaterally enlarged, firm ovaries. Laboratory investigations were ordered. Fasting blood glucose is 6.8 mmol/L, total testosterone is 3.5 nmol/L (normal range <2.5 nmol/L), LH is 18 IU/L, and FSH is 6 IU/L. Her prolactin and TSH levels are within normal limits. Given these findings, what is the most probable diagnosis and the cornerstone of initial therapeutic intervention?

A 28-year-old woman presents to an outpatient clinic with a 9-month history of worsening pelvic pain. She describes the pain as deep, cramping, and severe, primarily during her menstrual periods, but also experiencing daily lower abdominal aching that intensifies with physical activity. She also reports significant deep dyspareunia and increasing fatigue. She has tried over-the-counter pain relievers with minimal relief. Her past medical history is unremarkable, and she denies any recent infections or sexually transmitted diseases. On physical examination, her abdomen is soft with mild diffuse tenderness, but no rebound or guarding. A speculum exam is unremarkable. On bimanual examination, there is tenderness in the posterior cul-de-sac and a sensation of uterine retroversion with mild restricted mobility. Her urine beta-hCG is negative. Given her presentation and preliminary findings, what is the most likely diagnosis and the initial management approach?

A 48-year-old woman presents to an outpatient clinic with a sudden onset of left breast pain over the past three days. She describes the pain as localized and sharp, worsening significantly when she lifts her arm or reaches overhead. She denies any nipple discharge, fever, chills, or noticeable skin changes like redness or warmth. Her vital signs are stable: temperature 36.8°C, heart rate 72 bpm, blood pressure 128/78 mmHg, respiratory rate 16 breaths/min. On physical examination, a firm, tender, cord-like structure, approximately 5 cm in length, is palpated in the upper outer quadrant of her left breast. The overlying skin appears normal without erythema, warmth, or dimpling. There is no associated lymphadenopathy. Considering these findings, what is the most likely diagnosis and the immediate recommended therapeutic approach?

A 25-year-old woman, gravida 0, presents to an urgent care facility approximately 18 hours after experiencing unprotected sexual intercourse due to a condom failure. She expresses profound anxiety regarding potential pregnancy and emphasizes her firm desire to prevent it. Her last menstrual period began 10 days ago, suggesting she is likely in the follicular phase. She reports being in a stable, monogamous relationship for the past two years. Her past medical history is notable for an appendectomy six years prior and a brief period of oral contraceptive use three years ago; she is currently not on any regular medications and has no known allergies. Her family history includes diabetes, and her body mass index (BMI) is calculated at 31 kg/m². Physical examination, including a focused pelvic assessment, reveals no acute abnormalities. Considering her current presentation and reproductive goals, what is the most appropriate immediate management strategy and crucial element for subsequent follow-up?

A 28-year-old woman presents to her primary care provider's office with a chief complaint of recurring cyclical symptoms. For the past six months, she has experienced significant breast tenderness, severe abdominal bloating, and persistent fatigue, which consistently begin approximately 7 to 10 days prior to her menstrual period and resolve within the first day or two of menses. In addition to these physical symptoms, she reports marked irritability, frequent mood swings, and episodes of feeling overwhelmed or hopeless during this premenstrual phase. These symptoms have become severe enough to cause notable disruption in her professional life, leading to missed workdays, and have placed considerable strain on her personal relationships. She denies any new stressors, significant changes in diet or exercise, or other chronic medical conditions. Her vital signs are stable, and a comprehensive physical examination, including a pelvic exam, is unremarkable. What is the most likely diagnosis and the initial management strategy for this patient's condition?